Mackay Shields LLC Acadia Pharmaceuticals Inc Transaction History

Mackay Shields LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$36.42 - $57.0 $797,598 - $1.25 Million	-21,900 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$39.26 - $52.73 $1.64 Million - $2.2 Million	-41,777 Reduced 65.61%	21,900 $1.06 Million
Q1 2020 May 08, 2020	BUY	$31.65 - $46.87 $15,825 - $23,435	500 Added 0.79%	63,677 $2.69 Million
Q4 2019 Feb 11, 2020	SELL	$36.21 - $51.4 $470,730 - $668,200	-13,000 Reduced 17.07%	63,177 $2.7 Million
Q3 2019 Nov 01, 2019	SELL	$22.22 - $44.01 $233,310 - $462,105	-10,500 Reduced 12.11%	76,177 $2.74 Million
Q2 2019 Aug 13, 2019	BUY	$23.32 - $28.12 $1.29 Million - $1.55 Million	55,172 Added 175.12%	86,677 $2.32 Million
Q1 2019 May 13, 2019	SELL	$16.17 - $27.38 $11,319 - $19,166	-700 Reduced 2.17%	31,505 $846,000
Q4 2018 Feb 14, 2019	BUY	$14.32 - $22.92 $461,175 - $738,138	32,205 New	32,205 $520,000

290

158M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.06B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.